MARRONE BIO INNOVATIONS INC. Deferred Revenue
MARRONE BIO INNOVATIONS INC. had Deferred Revenue of $1.36 million as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2022-05-13
- 2022-03-31: Deferred Revenue $1.36M.
- 2021-12-31: Deferred Revenue $1.52M.
- 2021-09-30: Deferred Revenue $1.59M.
- 2021-06-30: Deferred Revenue $1.72M.
| Period end | Deferred Revenue |
|---|---|
| 2022-03-31 | $1.36M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.52M 10-Q · filed 2022-05-13 |
| 2021-09-30 | $1.59M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.72M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.97M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $2.00M 10-K/A · filed 2022-05-09 |
| 2020-09-30 | $2.23M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.35M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $2.33M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.41M 10-K · filed 2021-03-23 |
| 2019-09-30 | $2.53M 10-Q · filed 2019-11-19 |
| 2019-06-30 | $2.63M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $2.71M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $2.84M 10-K · filed 2020-03-16 |
| 2018-09-30 | $2.99M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $3.02M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.81M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $8.24M 10-K · filed 2019-03-29 |